Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Delforge

Showing results (61-70 of 103) with videos related to

Pageof 11
Sort By:
Revue Medicale De Liege|June 1, 1986
[Endoscopic treatment of esophageal stenosis]F Fontaine, C Drèze, H Lu Anh, et al.
Leukemia|September 7, 2007
Monocytes are activated in patients with myelodysplastic syndromes and can contribute to bone marrow failure through CD40-CD40L interactions with T helper cellsS Meers, A Kasran, L Boon, et al.
Revue Medicale De Liege|May 22, 2007
[Clinical case of the month. Hepatitis B reactivation in an Ag HBs negative patient]V Michels, B Bastens, M Delforge, et al.
British Journal of Haematology|August 8, 1998
Patients with high-risk myelodysplastic syndrome can have polyclonal or clonal haemopoiesis in complete haematological remissionM Delforge, H Demuynck, G Verhoef, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 20, 2013
Prospective observational study of treatment pattern, effectiveness and safety of zoledronic acid therapy beyond 24 months in patients with multiple myeloma or bone metastases from solid tumorsT Van den Wyngaert, M Delforge, C Doyen, et al.
Archives Des Maladies Du Coeur Et Des Vaisseaux|January 1, 1986
[Coronary vasomotor activity in man. Description of a method of quantification and normal values]J M Lablanche, B Didier, M Delforge, et al.
British Journal of Haematology|February 1, 1996
Feasibility of peripheral blood progenitor cell harvest and transplantation in patients with poor-risk myelodysplastic syndromesH Demuynck, M Delforge, G E Verhoef, et al.
Epidemiology and Infection|November 7, 2017
Hepatitis E virus (HEV): seroprevalence and HEV RNA detection in subjects attending a sexually transmitted infection clinic in Brussels, BelgiumN Dauby, V Suin, M Jacques, et al.
Leukemia|February 16, 2007
A new disease categorization of low-grade myelodysplastic syndromes based on the expression of cytopenia and dysplasia in one versus more than one lineage improves on the WHO classificationE Verburgh, R Achten, V J Louw, et al.
Acta Gastro-Enterologica Belgica|July 1, 1992
[Tolerance of adjuvant treatment combining postoperative intraportal chemotherapy and a systemic treatment based on 5-fluorouracil in colorectal carcinoma with a histologically poor prognosis]L Longree, C Focan, B Dallemagne, et al.
Pageof 11

Showing results (61-70 of 103) with videos related to

Sort By:
Pageof 11
Revue Medicale De Liege|June 1, 1986
[Endoscopic treatment of esophageal stenosis]F Fontaine, C Drèze, H Lu Anh, et al.
Leukemia|September 7, 2007
Monocytes are activated in patients with myelodysplastic syndromes and can contribute to bone marrow failure through CD40-CD40L interactions with T helper cellsS Meers, A Kasran, L Boon, et al.
Revue Medicale De Liege|May 22, 2007
[Clinical case of the month. Hepatitis B reactivation in an Ag HBs negative patient]V Michels, B Bastens, M Delforge, et al.
British Journal of Haematology|August 8, 1998
Patients with high-risk myelodysplastic syndrome can have polyclonal or clonal haemopoiesis in complete haematological remissionM Delforge, H Demuynck, G Verhoef, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 20, 2013
Prospective observational study of treatment pattern, effectiveness and safety of zoledronic acid therapy beyond 24 months in patients with multiple myeloma or bone metastases from solid tumorsT Van den Wyngaert, M Delforge, C Doyen, et al.
Archives Des Maladies Du Coeur Et Des Vaisseaux|January 1, 1986
[Coronary vasomotor activity in man. Description of a method of quantification and normal values]J M Lablanche, B Didier, M Delforge, et al.
British Journal of Haematology|February 1, 1996
Feasibility of peripheral blood progenitor cell harvest and transplantation in patients with poor-risk myelodysplastic syndromesH Demuynck, M Delforge, G E Verhoef, et al.
Epidemiology and Infection|November 7, 2017
Hepatitis E virus (HEV): seroprevalence and HEV RNA detection in subjects attending a sexually transmitted infection clinic in Brussels, BelgiumN Dauby, V Suin, M Jacques, et al.
Leukemia|February 16, 2007
A new disease categorization of low-grade myelodysplastic syndromes based on the expression of cytopenia and dysplasia in one versus more than one lineage improves on the WHO classificationE Verburgh, R Achten, V J Louw, et al.
Acta Gastro-Enterologica Belgica|July 1, 1992
[Tolerance of adjuvant treatment combining postoperative intraportal chemotherapy and a systemic treatment based on 5-fluorouracil in colorectal carcinoma with a histologically poor prognosis]L Longree, C Focan, B Dallemagne, et al.
Pageof 11